| |
| |
|
| Insider
Information: |
Pearlman Andrew |
| Relationship: |
Director |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
40,562 |
|
|
Indirect Shares
|
1,813 |
|
|
| Direct
Value |
$7,504 |
|
|
|
Indirect Value
|
$335 |
|
|
| Total
Shares |
42,375 |
|
|
| Total
Value |
$7,839 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aevi Genomic Medicine Inc |
GNMX |
Director |
2014-02-12 |
40,562 |
2014-02-12 |
1,813 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GNMX |
Aevi Genomic Medicine Inc |
Director |
– • – |
2014-02-12 |
4 |
AS |
$9.00 |
$100,512 |
D/D |
(11,168) |
40,562 |
0 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
Director |
– • – |
2014-02-12 |
4 |
OE |
$3.14 |
$35,068 |
D/D |
11,168 |
51,730 |
0 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
Director |
– • – |
2014-02-04 |
4 |
AS |
$8.00 |
$160,000 |
D/D |
(20,000) |
40,562 |
0 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
Director |
– • – |
2014-02-04 |
4 |
OE |
$2.49 |
$51,880 |
D/D |
20,000 |
60,562 |
0 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
Director |
– • – |
2014-01-30 |
4 |
AS |
$7.50 |
$183,750 |
D/D |
(24,500) |
40,562 |
0 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
Director |
– • – |
2014-01-30 |
4 |
OE |
$3.14 |
$76,930 |
D/D |
24,500 |
65,062 |
0 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
Director |
– • – |
2014-01-29 |
4 |
AS |
$7.50 |
$3,750 |
D/D |
(500) |
40,562 |
0 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
Director |
– • – |
2014-01-29 |
4 |
OE |
$3.14 |
$1,570 |
D/D |
500 |
41,062 |
0 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
Director |
– • – |
2014-01-09 |
4 |
AS |
$6.69 |
$230,578 |
D/D |
(34,466) |
40,562 |
0 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
Director |
– • – |
2014-01-09 |
4 |
OE |
$2.49 |
$89,720 |
D/D |
34,466 |
75,028 |
0 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
Director |
– • – |
2014-01-08 |
4 |
AS |
$6.54 |
$297,792 |
D/D |
(45,534) |
40,562 |
0 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
Director |
– • – |
2014-01-08 |
4 |
OE |
$2.49 |
$113,380 |
D/D |
45,534 |
86,096 |
0 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
Director |
– • – |
2014-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
7,000 |
40,562 |
0 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
President and CEO |
• • – |
2012-09-18 |
4 |
S |
$10.24 |
$51,200 |
D/D |
(5,000) |
33,562 |
0 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
President and CEO |
• • – |
2012-09-17 |
4 |
S |
$10.29 |
$61,740 |
D/D |
(6,000) |
38,562 |
0 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
President and CEO |
• • – |
2012-09-14 |
4 |
S |
$10.73 |
$42,920 |
D/D |
(4,000) |
44,562 |
0 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
President and CEO |
• • – |
2012-09-13 |
4 |
S |
$10.66 |
$209,181 |
D/D |
(19,623) |
48,562 |
0 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
President and CEO |
• • – |
2012-09-11 |
4 |
D |
$11.83 |
$671,707 |
D/D |
(56,780) |
68,185 |
0 |
- |
|
| GNMX |
Aevi Genomic Medicine Inc |
President and CEO |
• • – |
2012-09-11 |
4 |
OE |
$7.35 |
$671,812 |
D/D |
91,403 |
124,965 |
0 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
